-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
ELITE PHARMACEUTICALS INC /NV/ quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and change rate from Q4 2021 to Q3 2025.
- ELITE PHARMACEUTICALS INC /NV/ Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 30 Sep 2025 was $440,159.000, a 32.4% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)